BriaCell Therapeutics Corp.
- Stock
- Ticker BCTX
- ISIN CA1079303071
- Nasdaq
- US listing in dollars
Performance, volatility and drawdowns of BriaCell Therapeutics Corp. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $6. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −100.0% in 06/2026, measured from the peak in 03/2017. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 10/2024 | 01/2025 | 04/2025 | 07/2025 | 10/2025 | 01/2026 | 04/2026 | 07/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | -5.2 | -7.2 | -6.3 | -8.6 | -8.3 | -7.5 | -7.6 | -13 |
| EBITDA | -5.1 | -7.1 | -6.3 | -8.5 | -8.3 | -7.5 | -7.6 | -13 |
| Net income | -5.8 | -6.3 | -6.1 | -8.1 | -8.2 | -7.2 | -7.2 | -12 |
| Earnings per share | -32.67 | -23.31 | -16.42 | 4.89 | -4.35 | -2.58 | -0.99 | -1.24 |
| Balance sheet | ||||||||
| Total assets | 10 | 9.4 | 17 | 22 | 13 | 34 | 27 | 24 |
| Liabilities | 6.7 | 6.1 | 5.1 | 4.3 | 3.7 | 3.4 | 3.7 | 8.0 |
| Equity | 3.7 | 3.2 | 12 | 17 | 9.4 | 30 | 23 | 16 |
| Cash | 5.8 | 5.0 | 12 | 10 | 2.7 | 30 | 6.9 | 9.9 |
| Cash flow | ||||||||
| Operating cash flow | -7.0 | -5.9 | -7.2 | -8.1 | -7.7 | -8.0 | -7.0 | -6.0 |
| Capital expenditure | – | – | – | – | – | – | – | 0.0 |
| Free cash flow | -7.0 | -5.9 | -7.2 | -8.1 | -7.7 | -8.0 | -7.0 | -6.0 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2021 at +98.6%, weakest 2025 at −91.6%. 2 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 28 Oct 2026 | −$1.24 |
| 9 Jun 2026 | −$0.99 |
| 10 Mar 2026 | −$2.58 |
| 11 Dec 2025 | −$4.35 |
| 16 Oct 2025 | $4.89 |
| 16 Jun 2025 | −$16.42 |
| 12 Mar 2025 | −$23.31 |
| 16 Dec 2024 | −$32.67 |
| 29 Oct 2024 | −$40.32 |
| 14 Jun 2024 | $1.61 |
| 18 Mar 2024 | −$10.64 |
| 14 Dec 2023 | −$0.50 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €24m
- Market cap in trading currency
- $26.7m
- Enterprise value
- $6.18m
- P/E
- –
- P/S
- –
- P/B
- 1.72
- EV/Sales
- –
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -107.7%
Results (last four quarters)
- Revenue
- –
- Gross profit
- –
- EBITDA
- −$36.0m
- Net income
- −$34.9m
- Earnings per share
- −$6.97
- Revenue per share
- –
- Revenue growth
- –
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity
- -212.2%
- Return on assets
- -148.0%
Balance sheet and cash flow
- Cash
- $20.5m
- Cash per share
- $2.35
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 2.76
- Book value per share
- $1.78
- Operating cash flow
- −$28.7m
- Free cash flow
- −$28.8m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 8.73m
- Volume
- 108,869
- Avg. volume 3 months
- 262,025
- Relative volume
- 0.4
Price and technicals
- Price
- $3.06
- 1 day
- −3.2%
- 52-week high
- $12.64
- 52-week low
- $2.74
- Distance to 52-week high
- −75.8%
- Distance to 52-week low
- +11.7%
- Distance to 50-day line
- −16.9%
- Distance to 200-day line
- −18.1%
- RSI (14)
- 39
- Volatility 1M
- 93.1%
Performance
- 1 week
- −9.7%
- 1 month
- −10.3%
- 3 months
- −11.6%
- 6 months
- −12.3%
- YTD
- −57.0%
- 1 year
- −56.7%
Dates
- Fiscal year end
- 31 Jul 2026
- Most recent quarter
- 31 Jul 2026
Frequently asked questions
How has BCTX performed since 11/2016?
$10,000 grew to $6 by 20 Nov 2026, which is −52.4% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is BCTX?
Volatility was 88.4% per year, measured on monthly returns. The largest decline from a peak was −100.0%, with the low in 06/2026.
How does BCTX compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, BCTX returned −52.4% at 88.4%. The correlation of monthly returns was 0.18; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.
Why does this page show a US listing?
The figures use the stock's listing traded in the US. On individual days its path differs slightly from the price on the home exchange.